Abstract
Platinating agents are used in the treatment of a spectrum of childhood cancers. Oxaliplatin, a third generation platinum compound, may provide less toxicity and be more effective. A phase 2 study was performed to estimate the response rate to single agent oxaliplatin in patients with refractory pediatric solid tumors, and to further describe the toxicities and pharmacokinetics of the drug in this population. Subjects, < or =21 years of age at original diagnosis, received oxaliplatin (130 mg/m(2)) intravenously every 21 days. Prior platinum exposure was acceptable. Histologies included: Ewing sarcoma/peripheral PNET, osteosarcoma, rhabdomyosarcoma, neuroblastoma, high and low grade astrocytoma, brain stem glioma, ependymoma, hepatoblastoma and selected rare tumors. A two-stage design, enrolling 10 + 10 subjects, was used for each disease stratum. Limited sampling pharmacokinetic studies were performed. Of 124 eligible subjects (75 males), 113 were evaluable for response and 69 (62%) had received platinum previously. Only one objective response was observed, a partial response in a 6-year-old child with ependymoma. An additional 13 subjects with various other solid tumors had stable disease, receiving a median (range) of 13.5 (2...Continue Reading
References
Feb 15, 1992·Cancer·F LéviA Descorps-Declère
Jan 30, 1990·Biochemistry·J D PageS G Chaney
Jan 1, 1989·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·T TashiroY Kidani
Mar 1, 1986·Controlled Clinical Trials·M N Chang, P C O'Brien
Jun 1, 1985·Cancer Letters·G MathéE Chenu
Jan 1, 1995·Cancer Chemotherapy and Pharmacology·L PendyalaD Raghavan
Nov 2, 1994·Journal of the National Cancer Institute·F A LéviL Dogliotti
Jan 1, 1994·Cancer Chemotherapy and Pharmacology·S Y SharpL R Kelland
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LeviS Iacobelli
Dec 24, 1996·Biochemical Pharmacology·O RixeT Fojo
Jan 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D MachoverM Ychou
Jan 1, 1997·Investigational New Drugs·T A DunnJ Casper
Sep 18, 1997·Lancet·F LéviJ L Misset
May 30, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Díaz-RubioM Homerin
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Y BécouarnP Rougier
Nov 6, 1998·Molecular Pharmacology·J M WoynarowskiP Juniewicz
Apr 22, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A RiccardiR Riccardi
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S GiacchettiF Lévi
Feb 3, 2000·Journal of the National Cancer Institute·P TherasseS G Gwyther
Aug 11, 2000·Critical Reviews in Oncology/hematology·J L MissetE Cvitkovic
Dec 7, 2000·Journal of Pharmaceutical and Biomedical Analysis·J G MorrisonD Greenslade
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A G SorensenR Weisskoff
Jun 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M Bagley
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard H WilsonJean L Grem
Aug 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Renate Schmelz, Christian Lersch
Mar 21, 2003·Cancer Chemotherapy and Pharmacology·Jean-Pierre DelordEtienne Chatelut
May 31, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mace L RothenbergDaniel G Haller
Nov 5, 2003·Anti-cancer Drugs·G BastianS Urien
Feb 24, 2006·American Journal of Hematology·Brian R CurtisRichard H Aster
Jun 30, 2006·Critical Reviews in Oncology/hematology·Lara Maria PasettoSilvio Monfardini
Oct 5, 2006·Cancer·Maryam FouladiAmar Gajjar
Jun 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sheri L SpuntClinton F Stewart
Citations
Jun 19, 2012·Paediatric Drugs·Rajkumar VenkatramaniMarcio H Malogolowkin
Jun 5, 2014·Current Oncology Reports·Aaron WeissDamon Reed
Sep 25, 2012·Expert Opinion on Drug Discovery·Sushil KumarSylvain Baruchel
Sep 17, 2015·Pediatric Blood & Cancer·Michael S IsakoffKatherine A Janeway
Jan 18, 2012·Seminars in Pediatric Surgery·Dietrich von Schweinitz
Jul 30, 2011·Seminars in Cancer Biology·Ingrid Øra, Angelika Eggert
Oct 15, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Birgit GeoergerUNKNOWN European Consortium Innovative Therapies for Children with Cancer (ITCC)
Mar 11, 2016·Investigational New Drugs·Minghan ShiLéon Sanche
Jun 1, 2012·Pediatric Blood & Cancer·Angela D Trobaugh-Lotrario, James H Feusner
Oct 2, 2012·Pediatric Blood & Cancer·Margaret E MacyUNKNOWN Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC)
Jan 22, 2013·Pediatric Blood & Cancer·Leo MascarenhasRajkumar Venkatramani
Nov 20, 2015·Journal of Pediatric Hematology/oncology·Angela D Trobaugh-LotrarioJames H Feusner
Sep 22, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Tao HuangHao Qian
Jan 1, 2015·Pediatric Hematology and Oncology·Hung C TranLeo Mascarenhas
Mar 5, 2014·Biochimica Et Biophysica Acta·Guillaume BergtholdMark W Kieran
May 29, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Véronique Minard-ColinOdile Oberlin
Jan 6, 2015·Cancer Chemotherapy and Pharmacology·Mina NikanjamEdmund V Capparelli
Jun 20, 2014·Journal of Pediatric Hematology/oncology·Catherine G LamLisa M McGregor
May 11, 2016·Journal of Pediatric Hematology/oncology·Jonathan C YehKenneth J Cohen
Sep 25, 2016·Cancer Treatment Reviews·Tejaswi KandulaMichelle A Farrar
Oct 5, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maximilian I RugeJürgen Voges
Jul 13, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joanne P LagmayKatherine A Janeway
Aug 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael S IsakoffRichard Gorlick
Feb 18, 2017·Cancer·Howard M KatzensteinRebecka L Meyers
Feb 22, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Natacha OmerNathalie Gaspar
Sep 15, 2017·Expert Opinion on Investigational Drugs·Loredana AmorosoMirco Ponzoni
Jun 15, 2017·Pediatric Blood & Cancer·Roberto LukschMaura Massimino
Nov 1, 2018·Pediatric Blood & Cancer·Michael S IsakoffKatherine A Janeway
Dec 11, 2013·Current Opinion in Pediatrics·Piotr CzaudernaRebecka L Meyers
Jul 11, 2019·Oncology Letters·Jie XuWei Guo
Aug 4, 2020·Orthopedics·Shinji TsukamotoAndreas F Mavrogenis
Dec 19, 2017·Pediatric Blood & Cancer·Lillian M GuentherKatherine A Janeway
Nov 18, 2018·Cancer Chemotherapy and Pharmacology·Laure DeymeFlorence Gattacceca
May 11, 2021·Pediatrics and Neonatology·Jen-Yin HouHsi-Che Liu
Sep 9, 2021·Pediatric Blood & Cancer·Anderson B CollierKatherine A Janeway